日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy

肿瘤前哨淋巴结免疫迁移组学分析表明,CCR7⁺树突状细胞驱动对序贯免疫放射疗法的反应。

Robert Saddawi-Konefka ,Riyam Al Msari ,Shiqi Tang ,Chad Philips ,Sayed Sadat ,Lauren M Clubb ,Sarah Luna ,Santiago Fassardi ,Riley Jones ,Ida Franiak Pietryga ,Farhoud Faraji ,Shiruyeh Schokrpur ,Bryan S Yung ,Michael M Allevato ,Kelsey E Decker ,Chanond A Nasamran ,Daisy Chilin-Fuentes ,Sara Brin Rosenthal ,Shawn M Jensen ,Bernard A Fox ,R Bryan Bell ,J Silvio Gutkind ,Andrew Sharabi ,Joseph A Califano

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

FcyRIIB 是肿瘤微环境中限制 Treg 靶向抗体活性的新型免疫检查点

David Knorr, Rom Leidner, Shawn Jensen, Ryan Meng, Andrew Jones, Carmen Ballesteros-Merino, R Bryan Bell, Maria Baez, David Sprott, Carlo Bifulco, Brian Piening, Rony Dahan, Bernard A Fox, Jeffrey Ravetch

Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis

破坏肿瘤血管系统和募集负载PDL1的血小板可控制肿瘤转移

Hongjun Li ,Zejun Wang ,Zhaowei Chen ,Tianyuan Ci ,Guojun Chen ,Di Wen ,Ruoxin Li ,Jinqiang Wang ,Huan Meng ,R Bryan Bell ,Zhifeng Gu ,Gianpietro Dotti ,Zhen Gu

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

在头颈部鳞状细胞癌患者中,新辅助抗OX40(MEDI6469)疗法可激活并扩增抗原特异性肿瘤浸润T细胞。

Rebekka Duhen ,Carmen Ballesteros-Merino ,Alexandra K Frye ,Eric Tran ,Venkatesh Rajamanickam ,Shu-Ching Chang ,Yoshinobu Koguchi ,Carlo B Bifulco ,Brady Bernard ,Rom S Leidner ,Brendan D Curti ,Bernard A Fox ,Walter J Urba ,R Bryan Bell ,Andrew D Weinberg

Explant Modeling of the Immune Environment of Head and Neck Cancer

头颈癌免疫环境的外植体建模

Shay Sharon, Thomas Duhen, Shelly Bambina, Jason Baird, Rom Leidner, Bryan Bell, Nardy Casap, Marka Crittenden, Swetha Vasudevan, Maria Jubran, Nataly Kravchenko-Balasha, Michael Gough

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

局部区域 T 细胞免疫治疗平台用于控制 HNSCC 肿瘤切除后复发

Shay Sharon, Jason R Baird, Shelly Bambina, Gwen Kramer, Tiffany C Blair, Shawn M Jensen, Rom S Leidner, R Bryan Bell, Nardy Casap, Marka R Crittenden, Michael J Gough

REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial

RECUCE(通过日常实践中的密切监测审查长期抗抑郁药的使用)为长期服用抗抑郁药后停药的人群提供互联网和电话支持:一项随机对照试验方案

Kendrick, Tony; Geraghty, Adam W A; Bowers, Hannah; Stuart, Beth; Leydon, Geraldine; May, Carl; Yao, Guiqing; O'Brien, Wendy; Glowacka, Marta; Holley, Simone; Williams, Samantha; Zhu, Shihua; Dewar-Haggart, Rachel; Palmer, Bryan; Bell, Margaret; Collinson, Sue; Fry, Imogen; Lewis, Glyn; Griffiths, Gareth; Gilbody, Simon; Moncrieff, Joanna; Moore, Michael; Macleod, Una; Little, Paul; Dowrick, Christopher

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

CD39和CD103的共表达可识别人类实体瘤中的肿瘤反应性CD8 T细胞

Thomas Duhen ,Rebekka Duhen ,Ryan Montler ,Jake Moses ,Tarsem Moudgil ,Noel F de Miranda ,Cheri P Goodall ,Tiffany C Blair ,Bernard A Fox ,Jason E McDermott ,Shu-Ching Chang ,Gary Grunkemeier ,Rom Leidner ,Richard Bryan Bell ,Andrew D Weinberg

Stat5 Is Required for CD103+ Dendritic Cell and Alveolar Macrophage Development and Protection from Lung Injury

Stat5 是 CD103+ 树突状细胞和肺泡巨噬细胞发育以及保护肺损伤所必需的

William E Eddy, Ke-Qin Gong, Bryan Bell, William C Parks, Steven F Ziegler, Anne M Manicone

OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer

OX40、PD-1 和 CTLA-4 在头颈癌中选择性地表达于肿瘤浸润 T 细胞上。

Ryan Montler ,R Bryan Bell ,Colin Thalhofer ,Rom Leidner ,Zipei Feng ,Bernard A Fox ,Allen C Cheng ,Tuan G Bui ,Christopher Tucker ,Helena Hoen ,Andrew Weinberg